Whitepaper: Biomarkers and mechanisms of toxicity
Posted: 23 February 2021 | Eurofins Discovery | No comments yet
Phenotypic profiling identifies biomarkers and mechanisms of toxicity.
Small animal models such as mice and rats are poor predictors of skin reactions in humans. Until candidates are tested in expensive human safety trials or in non-human primate models, potential skin reactions are difficult to predict. The BioMAP® Phenotypic Profiling Platform provides a robust and reliable alternative path to the resource-heavy traditions of animal testing and conventional preclinical procedures.
Related content from this organisation
- Human iPSC-derived cardiomyocytes for cardiac proarrhythmic risk assessment
- Flyer: Introducing Eurofins Beacon Discovery; the GPCR experts
- Cardiac proarrhythmic risk assessment using human-induced pluripotent stem cell-derived cardiomyocytes
- Automating functional cell-based bioassays: assay reproducibility and performance for potency testing programmes
- Hit discovery for GPCRs: HTS or virtual screens?
Related topics
Assays, Biopharmaceuticals, Disease research, Hit-to-Lead, Screening, Targets
Related organisations
Eurofins Discovery
